Item Type | Name |
Academic Article
|
Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin.
|
Academic Article
|
Clinical outcomes of steroid-insensitive asthma.
|
Academic Article
|
Alternative treatments for asthma: assessing the need.
|
Academic Article
|
Brief report: therapeutic manipulations in severe nocturnal asthma. A nonconventional approach in a severe high-risk asthmatic.
|
Academic Article
|
An evaluation of colchicine as an alternative to inhaled corticosteriods in moderate asthma. National Heart, Lung, and Blood Institute's Asthma Clinical Research Network.
|
Academic Article
|
Systemic effect comparisons of six inhaled corticosteroid preparations.
|
Academic Article
|
Airway tissue mast cells in persistent asthma: predictor of treatment failure when patients discontinue inhaled corticosteroids.
|
Academic Article
|
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial.
|
Academic Article
|
Safety and application of induced sputum analysis in childhood asthma.
|
Academic Article
|
Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma.
|
Academic Article
|
Predicting worsening asthma control following the common cold.
|
Academic Article
|
Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial.
|
Academic Article
|
Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.
|
Academic Article
|
Predictors of remitting, periodic, and persistent childhood asthma.
|
Academic Article
|
A trial of clarithromycin for the treatment of suboptimally controlled asthma.
|
Academic Article
|
The utility of peak flow, symptom scores, and beta-agonist use as outcome measures in asthma clinical research.
|
Academic Article
|
Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial.
|
Academic Article
|
P2X7-regulated protection from exacerbations and loss of control is independent of asthma maintenance therapy.
|
Academic Article
|
Evolving role of theophylline for treatment of chronic childhood asthma.
|
Academic Article
|
Significant variability in response to inhaled corticosteroids for persistent asthma.
|
Academic Article
|
Psychological change associated with theophylline treatment of asthmatic children: a 6-month study.
|
Academic Article
|
The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma.
|
Academic Article
|
beta-Adrenergic receptor polymorphisms and response to salmeterol.
|
Academic Article
|
Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents.
|
Academic Article
|
Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma.
|
Academic Article
|
The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial.
|
Academic Article
|
Lessons learned from variation in response to therapy in clinical trials.
|
Academic Article
|
Tiotropium bromide step-up therapy for adults with uncontrolled asthma.
|
Academic Article
|
Urinary leukotriene E4/exhaled nitric oxide ratio and montelukast response in childhood asthma.
|
Academic Article
|
Adherence to inhaled corticosteroids: an ancillary study of the Childhood Asthma Management Program clinical trial.
|
Academic Article
|
New insights into asthma pathogenesis and treatment.
|
Concept
|
Drug Therapy, Combination
|
Concept
|
Medication Therapy Management
|
Concept
|
Treatment Outcome
|
Concept
|
Combined Modality Therapy
|
Concept
|
Therapeutic Equivalency
|
Concept
|
Biological Therapy
|
Concept
|
Treatment Failure
|
Academic Article
|
Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children.
|
Academic Article
|
Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study.
|
Academic Article
|
Daily or intermittent budesonide in preschool children with recurrent wheezing.
|
Academic Article
|
Steroid-specific and anticonvulsant interaction aspects of troleandomycin-steroid therapy.
|
Academic Article
|
Dose- and time-related effect of troleandomycin on methylprednisolone elimination.
|
Academic Article
|
Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: a 6-month, open- label, randomized trial.
|
Academic Article
|
Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma.
|
Academic Article
|
Current concepts in asthma treatment in children.
|
Academic Article
|
Steroid therapy for asthma in children.
|
Academic Article
|
Development and validation of the Composite Asthma Severity Index--an outcome measure for use in children and adolescents.
|
Academic Article
|
Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program.
|
Academic Article
|
Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial.
|
Academic Article
|
Sustained release theophylline preparations. Practical recommendations for prescribing and therapeutic drug monitoring.
|
Academic Article
|
Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children.
|
Academic Article
|
Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children.
|
Academic Article
|
Corticosteroid therapy in asthma: predictors of responsiveness.
|
Academic Article
|
Impulse oscillometry versus spirometry in a long-term study of controller therapy for pediatric asthma.
|
Academic Article
|
Management of chronic asthma.
|
Academic Article
|
Anti-inflammatory drugs in the treatment of allergic disease.
|
Academic Article
|
Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma.
|
Academic Article
|
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids.
|
Academic Article
|
High-dose systemic glucocorticoid therapy in the treatment of severe asthma: a case of resistance and patterns of response.
|
Academic Article
|
Long-term inhaled corticosteroids in preschool children at high risk for asthma.
|
Academic Article
|
Asthma pathogenesis and the implications for therapy in children.
|
Academic Article
|
Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma.
|
Academic Article
|
The safety of inhaled corticosteroid therapy in children.
|
Academic Article
|
Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locus.
|
Academic Article
|
Inhaled therapy in infants: why not nebulize glucocorticoids?
|
Academic Article
|
Alternative therapy in severe asthma.
|
Academic Article
|
Corticosteroid therapy in adolescent patients.
|
Academic Article
|
Inhaled glucocorticoid therapy in children: how much is safe?
|
Academic Article
|
Effect of low-dose troleandomycin on theophylline clearance: implications for therapeutic drug monitoring.
|
Academic Article
|
Adrenal function in adult asthmatics during long-term daily treatment with 800, 1,200, and 1,600 micrograms triamcinolone acetonide. Multicenter study.
|
Academic Article
|
Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma.
|
Academic Article
|
Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
|
Academic Article
|
Role of budesonide as maintenance therapy for children with asthma.
|
Academic Article
|
Prednisolone and methylprednisolone kinetics in children receiving anticonvulsant therapy.
|
Academic Article
|
Theophylline absorption from two sustained-release products. Implications for therapeutic drug monitoring.
|
Academic Article
|
Oral corticosteroids in poorly controlled asthma.
|
Academic Article
|
Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma.
|
Academic Article
|
Regular inhaled beta-adrenergic agonists in the treatment of bronchial asthma: beneficial or detrimental?
|
Academic Article
|
Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma.
|
Academic Article
|
Challenges in assessing outcomes for pediatric asthma.
|
Academic Article
|
Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial.
|
Academic Article
|
Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial.
|
Academic Article
|
Identifying the child in need of asthma therapy.
|
Academic Article
|
Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study.
|
Academic Article
|
Inconsistent absorption from a sustained-release theophylline preparation during continuous therapy in asthmatic children.
|
Academic Article
|
Leukotriene modifiers: what is their position in asthma therapy?
|
Academic Article
|
Coexistence of glucocorticoid receptor and pharmacokinetic abnormalities: factors that contribute to a poor response to treatment with glucocorticoids in children with asthma.
|
Academic Article
|
Glucocorticoid therapy for asthma: clinical pharmacology.
|
Academic Article
|
Airway remodeling: therapeutic target or not?
|
Academic Article
|
Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy.
|
Academic Article
|
Alternative agents for anti-inflammatory treatment of asthma.
|
Academic Article
|
Immunologic basis and management of steroid-resistant asthma.
|
Academic Article
|
Efficacy and safety of low-dose troleandomycin therapy in children with severe, steroid-requiring asthma.
|
Academic Article
|
Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
|
Academic Article
|
In utero smoke (IUS) exposure has been associated with increased prevalence of asthma and reduced lung function in healthy children.
|
Academic Article
|
Clarithromycin potentiates glucocorticoid responsiveness in patients with asthma: results of a pilot study.
|
Academic Article
|
Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: role of predictors in the setting of high adherence.
|
Academic Article
|
Efficacy of atropine methylnitrate alone and in combination with albuterol in children with asthma.
|
Academic Article
|
Monitoring glucocorticoid therapy: a pharmacokinetic approach.
|
Academic Article
|
Predictors of poor response during asthma therapy differ with definition of outcome.
|
Academic Article
|
Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy.
|
Academic Article
|
Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma.
|
Academic Article
|
Inhibition of methylprednisolone elimination in the presence of erythromycin therapy.
|
Academic Article
|
The role of theophylline in the treatment of asthma.
|
Academic Article
|
Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial.
|
Academic Article
|
Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children.
|
Academic Article
|
Corticosteroid treatment of asthma: now at the crossroads. Reply to Drs Seale and Donnelly.
|
Academic Article
|
Meeting needs of infants and young children with asthma: new developments in nebulized corticosteroid therapy. Introduction.
|
Academic Article
|
Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network.
|
Academic Article
|
Predictors of response to tiotropium versus salmeterol in asthmatic adults.
|
Academic Article
|
Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma.
|
Academic Article
|
Individualizing asthma therapy: application of biomarkers.
|
Academic Article
|
Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma.
|
Academic Article
|
Childhood asthma clusters and response to therapy in clinical trials.
|
Academic Article
|
Eczema and race as combined determinants for differential response to step-up asthma therapy.
|
Academic Article
|
Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab.
|
Academic Article
|
A randomised dose-ranging study of tiotropium Respimat? in children with symptomatic asthma despite inhaled corticosteroids.
|
Academic Article
|
Monitoring asthma in childhood: symptoms, exacerbations and quality of life.
|
Academic Article
|
Markers of Differential Response to Inhaled Corticosteroid Treatment Among Children with Mild Persistent Asthma.
|
Academic Article
|
Impact of Age and Sex on Response to Asthma Therapy.
|
Academic Article
|
New and future strategies to improve asthma control in children.
|
Academic Article
|
Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations.
|
Academic Article
|
Intermittent steroid inhalation for the treatment of childhood asthma.
|
Academic Article
|
Tiotropium add-on therapy in adolescents with moderate asthma: A?1-year randomized controlled trial.
|
Academic Article
|
Advances in asthma 2015: Across the lifespan.
|
Academic Article
|
Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort.
|
Academic Article
|
Individualized therapy for persistent asthma in young children.
|
Academic Article
|
Effect of asthma therapies on the natural course of asthma.
|
Academic Article
|
Tiotropium for the treatment of asthma in adolescents.
|
Academic Article
|
A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma.
|
Academic Article
|
Can we predict fall asthma exacerbations? Validation of the seasonal asthma exacerbation index.
|
Academic Article
|
Long-term effects of budesonide or nedocromil in children with asthma.
|
Grant
|
CAMP Contiunation Study/Phase 3
|
Grant
|
PEDIATRIC PHARMACOLOGY RESEARCH UNIT
|
Grant
|
Progression of Airway Obstruction in Childhood Asthma
|
Grant
|
Childhood Asthma Research and Education Network: Denver Site
|
Grant
|
Clinical Centers for the NHLBI Asthma Network (AsthmaNet)
|
Academic Article
|
More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II.
|
Academic Article
|
Does inhaled steroid therapy help emerging asthma in early childhood?
|
Academic Article
|
Approaching Current and New Drug Therapies for Pediatric Asthma.
|
Academic Article
|
Safety and efficacy of tiotropium in children aged 1-5 years with persistent asthmatic symptoms: a randomised, double-blind, placebo-controlled trial.
|
Academic Article
|
Controlling the Risk Domain in Pediatric Asthma through Personalized Care.
|
Academic Article
|
Efficacy and Safety of Tiotropium in Children and Adolescents.
|
Academic Article
|
The pediatric asthma yardstick: Practical recommendations for a sustained step-up in asthma therapy for children with inadequately controlled asthma.
|
Academic Article
|
Challenges in the treatment of asthma in children and adolescents.
|
Academic Article
|
Boehringer-Ingelheim Satellite Symposium Choosing the Right Controller Therapy in Pediatric Patients with Asthma.
|
Academic Article
|
Racial Disparities in Asthma-Related Health Outcomes in Children with Severe/Difficult-to-Treat Asthma.
|
Academic Article
|
Use of Oral Corticosteroids in the Wheezy Toddler.
|
Academic Article
|
Current State and Future of Biologic Therapies in the Treatment of Asthma in Children.
|
Academic Article
|
What Is the Role of Increasing Inhaled Corticosteroid Therapy in Worsening Asthma in Children?
|
Academic Article
|
Can early intervention in pediatric asthma improve long-term outcomes? A question that needs an answer.
|
Academic Article
|
Cost-effectiveness and comparative effectiveness of biologic therapy for asthma: To biologic or not to biologic?
|
Academic Article
|
Outcomes for Pediatric Asthmatic Inpatients After Implementation of an Emergency Department Dexamethasone Treatment Protocol.
|
Academic Article
|
Tiotropium Is Efficacious in 6- to 17-Year-Olds with Asthma, Independent of T2 Phenotype.
|
Concept
|
Molecular Targeted Therapy
|
Academic Article
|
Tiotropium add-on therapy is safe and?reduces seasonal worsening in paediatric?asthma patients.
|
Academic Article
|
Safety of tiotropium Respimat? in black or African-American patients with symptomatic asthma.
|
Academic Article
|
Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma.
|
Academic Article
|
Challenges in managing difficult-to-treat asthma in children: Stop, look, and listen.
|
Academic Article
|
An expert consensus framework for asthma remission as a treatment goal.
|
Academic Article
|
Paradigm Shift in Asthma Therapy for Adolescents: Should It Apply to Younger Children as Well?
|
Academic Article
|
Using fractional exhaled nitric oxide to guide step-down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis.
|
Academic Article
|
Does treatment guided by exhaled nitric oxide fraction improve outcomes in subgroups of children with asthma?
|
Academic Article
|
Treatment Benefit with Omalizumab in Children by Indicators of Asthma Severity.
|
Academic Article
|
Using fractional exhaled nitric oxide to guide step-down treatment decisions in asthma: practical considerations.
|
Academic Article
|
Possible Protective Effect of Omalizumab on Lung Function Decline in Patients Experiencing Asthma Exacerbations.
|
Academic Article
|
Ongoing asthma management in children during the COVID-19 pandemic: to step down or not to step down?
|
Academic Article
|
Response to Omalizumab in Black and White Patients with Allergic Asthma.
|
Academic Article
|
Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma.
|
Academic Article
|
Adding a Biologic to Asthma Therapy: The Role of Adherence in Selecting the Right Patient.
|
Academic Article
|
Treating asthma in the time of COVID.
|
Academic Article
|
Factors to Consider in Prescribing Asthma Biologic Therapies to Children.
|
Academic Article
|
Is the assessment of asthma treatment efficacy sufficiently comprehensive?
|